UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052318
Receipt number R000059716
Scientific Title Feasibility study of a frailty prevention program for patients with rheumatoid arthritis
Date of disclosure of the study information 2023/10/01
Last modified on 2025/04/01 22:49:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility study of a frailty prevention program for patients with rheumatoid arthritis

Acronym

Feasibility study of a frailty prevention program for patients with rheumatoid arthritis

Scientific Title

Feasibility study of a frailty prevention program for patients with rheumatoid arthritis

Scientific Title:Acronym

Feasibility study of a frailty prevention program for patients with rheumatoid arthritis

Region

Japan


Condition

Condition

Rheumatoid Arthritis

Classification by specialty

Clinical immunology Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study was to examine the feasibility of implementing a frailty prevention program for outpatients with rheumatoid arthritis.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

persistence rate of exercise

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

The exercise program including resistance training and aerobic exercise will be provided for subjects for seven times in 12 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) with a low disease activity
2) could answer the questionnaire by themselves
3) could come to hospital for exercise training

Key exclusion criteria

1) using a wheelchair
2) are deemed ineligible for enrollment by the responsible researcher or co-researcher

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Mikako
Middle name
Last name Yasuoka

Organization

National Center for Geriatrics and Gerontology

Division name

Department of Frailty Research

Zip code

474-8511

Address

7-430 Morioka-cho, Obu, Aichi, 474-8511, Japan

TEL

0562-46-2311

Email

myasuoka52@outlook.jp


Public contact

Name of contact person

1st name Mikako
Middle name
Last name Yasuoka

Organization

National Center for Geriatrics and Gerontology

Division name

Department of Frailty Research

Zip code

Department of Frailty Research

Address

7-430 Morioka-cho, Obu, Aichi, 474-8511, Japan

TEL

0562-46-2311

Homepage URL


Email

myasuoka52@outlook.jp


Sponsor or person

Institute

National Center for Geriatrics and Gerontology

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research and Medical Division

Address

7-430 Morioka-cho Obu Aichi Japan

Tel

0562-46-2311

Email

yaday@ncgg.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 08 Month 10 Day

Date of IRB

2023 Year 08 Month 10 Day

Anticipated trial start date

2023 Year 10 Month 06 Day

Last follow-up date

2024 Year 01 Month 05 Day

Date of closure to data entry

2024 Year 12 Month 20 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 09 Month 27 Day

Last modified on

2025 Year 04 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059716